PALVELLA THERAPEUTICS, INC. (PVLA) › RevenuePALVELLA THERAPEUTICS, INC. (PVLA) — RevenueAnnual figures by fiscal year, from SEC filings.2013: $12.43M2014: $5.37M2015: $2.93M2016: $5.83M2017: $25.27M2018: $29.10M2019: $46.28M2020: $29.32M2021: $31.42M2022: $25.90M2023: $42.81M$42.81M2013Revenue (USD)2023Fiscal YearRevenueChange YoY2023$42.81M+65.3%2022$25.90M-17.6%2021$31.42M+7.1%2020$29.32M-36.6%2019$46.28M+59.0%2018$29.10M+15.1%2017$25.27M+333.5%2016$5.83M+98.9%2015$2.93M-45.4%2014$5.37M-56.8%2013$12.43M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share